MD Anderson Events
Use of Vemerafenib in Metastatic Melanoma
- Review common targeted therapy treatment of metastatic melanoma
- Identify pathology findings that indicate a patient is a candidate for BRAF inhibitors
- Identify patients characteristics that indicate use of BRAF inhibitors
- State toxicities of BRAF inhibitors and associated nursing interventions
- Discuss how BRAF is used in combinations therapies
Date: 3/26/13, 1:30pm to 2:30pm
Time: 3/26/13, 1:30pm to 2:30pm
Location: P10 Conference Room
Format: Training/Employee Development
CME: Contact Hours: 1.0
Speaker: Tina Dett, FNP
Contact: Cindy Murphy - 39297 - cmurphy@mdanderson.org
Related Events
- Webinar: Writing Clinical Case Reports
- Third Thursday Writing Retreat
- 70th Anniversary Brown Bag: Writing the Introduction Section of a Research Article
- Third Thursday Writing Retreat
- 70th Anniversary Brown Bag: Significance and Innovation in R01 Proposals
- 70th Anniversary Brown Bag: Rhetorical Techniques for Fine-Tuning Your Writing
- 70th Anniversary Brown Bag: NIH Study Sections
Contact Us
Questions? Need help?
Want to request an appointment?
Call askMDAnderson
1-877-MDA-6789